Astrotech

Astrotech Announces Listing to the GSA as an Approved United States Government Vendor

Retrieved on: 
Monday, April 8, 2024
Astrotech, SDVOSB, Conference, Transport, ETD, Intelligence, Knowledge, NTD, Aviation, European Civil Aviation Conference, Small business, GSA, Mass spectrometry, TSA, ASTC, TRACER

AUSTIN, Texas, April 08, 2024 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ: ASTC) ("Astrotech" or the "Company") and its wholly owned subsidiary, 1st Detect Corporation (1st Detect), announce that 1st Detect’s TRACER 1000TM is now listed in the U.S. General Services Administration (GSA) IT Schedule 70 under Contract No. GS-35F-250GA with SRI Group LLC, Special Item Number 334290.   IT Schedule 70 is a long-term contract issued by the GSA to commercial technology vendors that allows sales to the U. S. federal government, one of the largest buyers of goods and services in the world. GSA’s thorough evaluation determined that 1st Detect’s pricing is fair and reasonable, that 1st Detect had the requisite capabilities, organizational structure, customer satisfaction and performance history, and that the offered products and services are compliant with applicable laws and regulations.

Key Points: 
  • IT Schedule 70 is a long-term contract issued by the GSA to commercial technology vendors that allows sales to the U. S. federal government, one of the largest buyers of goods and services in the world.
  • The TRACER 1000 maintains the accuracy of much larger mass spectrometers even though it is only the size of a desktop printer.
  • The Astrotech Mass Spectrometer Technology™ drives the breakthrough TRACER 1000, as the first certified ETD to employ mass spectrometry.
  • 1st Detect has engaged with SRI Group LLC, a distinguished GSA provider led by retired Deputy Administrator of the Transportation Security Administration (TSA) John Halinski.

Astrotech to Showcase the Tracer 1000 Trace Detector at ISC West Conference

Retrieved on: 
Tuesday, April 2, 2024
Narcotic, Certification, Astrotech, Conference, Heroin, Cocaine, ETD, International, Law enforcement, NTD, Prison, European Civil Aviation Conference, Exposition, Astrotech Corporation, Airport, Mass spectrometry, ASTC, TRACER, Fentanyl, Drug

The TRACER 1000 is a high-performance laboratory instrument that is powered by the Astrotech Mass Spectrometer Technology™ (“AMS Technology”).

Key Points: 
  • The TRACER 1000 is a high-performance laboratory instrument that is powered by the Astrotech Mass Spectrometer Technology™ (“AMS Technology”).
  • Currently, the Company’s Tracer 1000 ETD is now found in multiple locations in 14 countries throughout the world.
  • “We are extremely excited to share our user-friendly mass spectrometer the TRACER 1000, which is powered by our AMS Technology, with leading industry experts and security industry professionals at the ISC West conference.
  • The TRACER 1000 is the first mass spectrometry-based ETD to have received European Civil Aviation Conference (“ECAC”) certification for both checkpoint and cargo security.

Astrotech Introduces the “Gold Standard” of Mass Spectrometry into Narcotics Detection Market with its State-of-the-Art Tracer 1000

Retrieved on: 
Monday, March 25, 2024
Astrotech, Conference, Heroin, Cocaine, ETD, Law enforcement, NTD, Prison, European Civil Aviation Conference, Airport, Mass spectrometry, ASTC, TRACER, Fentanyl, Drug

The TRACER 1000 NTD is a high-performance laboratory instrument capable of rapid detection of trace levels of narcotic compounds in seconds.

Key Points: 
  • The TRACER 1000 NTD is a high-performance laboratory instrument capable of rapid detection of trace levels of narcotic compounds in seconds.
  • Currently, the Company’s Tracer 1000 Explosive Trace Detector (ETD) is now found in multiple locations in 14 countries throughout the world.
  • The Astrotech Mass Spectrometer Technology™ (AMS Technology) drives the breakthrough TRACER 1000, as the first certified ETD to employ mass spectrometry as a trace detection security solution.
  • The TRACER 1000 is the only mass spectrometry-based ETD to have received European Civil Aviation Conference certification for both checkpoint and cargo security.

IBN Coverage Initiated for Astrotech Corp.

Retrieved on: 
Wednesday, January 17, 2024
ASTC, Astrotech, Social media, Agriculture, ECAC, TRACER, ATI Technologies, IBN, Airport, ETD, Certification

Through its Astrotech Technology Inc. (ATi) subsidiary, Astrotech owns and licenses proprietary mass spectrometry solutions for a variety of industries and applications.

Key Points: 
  • Through its Astrotech Technology Inc. (ATi) subsidiary, Astrotech owns and licenses proprietary mass spectrometry solutions for a variety of industries and applications.
  • Other applications for the company’s technology include AgLAB-1000, a process control system, and the BreathTest 1000, a disease detection solution.
  • Astrotech also announced the creation of its newest wholly owned subsidiary, Pro-Control Inc., which has an exclusive ATi field-of-use license for worldwide chemical manufacturing and process control applications.
  • IBN is uniquely positioned to provide Astrotech the solutions needed to reach a wide audience of investors, journalists and the general public.

Astrotech Announces Exciting New Technology Application and Introduces New Subsidiary

Retrieved on: 
Tuesday, December 12, 2023
IBN, Distillation, Astrotech, ASTC, Pressure

AUSTIN, Texas, Dec. 12, 2023 (GLOBE NEWSWIRE) -- - via IBN - Astrotech Corporation (NASDAQ:ASTC) ("Astrotech" or the "Company") announces formation of a wholly owned subsidiary Pro-Control, Inc. (“Pro-Control”) and has entered into an exclusive license to use the ATi Mass Spectrometer Technology for chemical manufacturing process control applications.

Key Points: 
  • AUSTIN, Texas, Dec. 12, 2023 (GLOBE NEWSWIRE) -- - via IBN - Astrotech Corporation (NASDAQ:ASTC) ("Astrotech" or the "Company") announces formation of a wholly owned subsidiary Pro-Control, Inc. (“Pro-Control”) and has entered into an exclusive license to use the ATi Mass Spectrometer Technology for chemical manufacturing process control applications.
  • Pro-Control MVPTM uses advanced mass spectrometer instrumentation to monitor and control the fractional distillation of bulk chemicals using real-time in-process samples.
  • Pro-Control MVPTM provides the vital spectral qualitative and quantitative data needed to control the distillation parameters (temps, flow, speed, pressure) while significantly improving efficiency.
  • The Pro-Control MVPTM rapid test can take up to 20 tests per hour providing ideal testing conditions to greatly increase efficiency.

ASTROTECH BOARD UNANIMOUSLY REJECTS UNSOLICITED ACQUISITION PROPOSAL FROM BML INVESTMENT PARTNERS, L.P.

Retrieved on: 
Friday, June 30, 2023
Cleveland Clinic, Partnership, Astrotech Corporation, ASTC, History, Sale, BML, Acquisition, Investment, Risk management, Security (finance), Holding company, Proposal, Astrotech

AUSTIN, Texas, June 30, 2023 (GLOBE NEWSWIRE) -- Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) today announced that its Board of Directors (the “Board”) has unanimously rejected the unsolicited acquisition proposal from BML Investment Partners, L.P. (“BML”), received on June 26, 2023, to acquire all of the outstanding shares of common stock of the Company for $17.25 per share in cash (the “Proposal”).

Key Points: 
  • AUSTIN, Texas, June 30, 2023 (GLOBE NEWSWIRE) -- Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) today announced that its Board of Directors (the “Board”) has unanimously rejected the unsolicited acquisition proposal from BML Investment Partners, L.P. (“BML”), received on June 26, 2023, to acquire all of the outstanding shares of common stock of the Company for $17.25 per share in cash (the “Proposal”).
  • Our board has reviewed the BML proposal and believes that it is grossly undervalued,” stated Thomas B. Pickens III, CEO and CTO of Astrotech.
  • The Board believes that the Proposal significantly undervalues the Company and prioritizes the short-term gain of BML at the expense of the Company’s stockholders.
  • The Board believes the Proposal is an opportunistic attempt by BML to purchase the Company’s shares at a discounted price that significantly undervalues the Company’s business.

ASTROTECH CONFIRMS RECEIPT OF UNSOLICTED NON-BINDING ACQUISITION PROPOSAL

Retrieved on: 
Tuesday, June 27, 2023
Astrotech, Astrotech Corporation, BML, ATM, Acquisition, ASTC, Tail, Cryptocurrency, Financial adviser

The non-binding proposal states that BML holds 13% of the Company’s outstanding shares.

Key Points: 
  • The non-binding proposal states that BML holds 13% of the Company’s outstanding shares.
  • Effective June 27, 2023, the Company terminated the ATM Agreement in accordance with its terms.
  • Consistent with its fiduciary duties, the Company’s board of directors will evaluate the non-binding proposal to determine the course of action that it believes is in the best interest of the Company and all Astrotech stockholders and respond appropriately.
  • The Astrotech stockholders do not need to take any action at this time.

ASTROTECH ANNOUNCES CONFIRMED AGLAB, INC. FIELD TRIAL RESULTS

Retrieved on: 
Tuesday, May 9, 2023
Cannabis, MVP, Astrotech Corporation, THC, Oil, ASTC, Salvinia minima, Medicinal plants, CBD, Astrotech

AUSTIN, Texas, May 09, 2023 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ: ASTC) (the “Company”), is announcing today that its subsidiary, AgLAB, Inc., confirmed the results from field trials using the AgLAB 1000-D2TM mass spectrometer and the Maximum Value ProcessTM testing method (“AgLAB MVP”).

Key Points: 
  • AUSTIN, Texas, May 09, 2023 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ: ASTC) (the “Company”), is announcing today that its subsidiary, AgLAB, Inc., confirmed the results from field trials using the AgLAB 1000-D2TM mass spectrometer and the Maximum Value ProcessTM testing method (“AgLAB MVP”).
  • AgLAB MVP is designed to improve yields and bottom-line profits for hemp (CBD) and cannabis (THC) producers of distilled oils.
  • Large scale CBD and THC oil processors use molecular distillation systems (“MDS”) to produce the valuable oils that are used in lotions, pills, tinctures, and cartridges.
  • During our field trials, we were able to improve ending-weight yields by an average of 30%, increasing customer profitability,” stated Thomas B. Pickens III, CEO and CTO of Astrotech.

Astrotech Reports Second Quarter of Fiscal Year 2023 Financial Results

Retrieved on: 
Monday, February 13, 2023
Bank statement, ATI, ASTC, III, Maintenance, ETD, Cannabis, Federation, Astrotech Corporation, Food, TRACER, Information technology, Marketing, Share repurchase, Salvinia minima, Regulation of tobacco by the U.S. Food and Drug Administration, Cryptocurrency, Management, Astrotech

AUSTIN, Texas, Feb. 13, 2023 (GLOBE NEWSWIRE) -- Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) reported its financial results for its second quarter of fiscal year 2023, which ended December 31, 2022.

Key Points: 
  • AUSTIN, Texas, Feb. 13, 2023 (GLOBE NEWSWIRE) -- Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) reported its financial results for its second quarter of fiscal year 2023, which ended December 31, 2022.
  • The decrease in revenue from the prior fiscal year is primarily the result of Astrotech shifting focus from the volatile ETD market to commercialization and marketing of the AgLAB 1000-D2.
  • Year-to-date gross margin increased to 38% from 18%, an increase of 111%, for fiscal year 2023, compared to fiscal year 2022, due to the higher margins provided by recurring maintenance services and consumables sales.
  • Astrotech expanded the size of its Board of Directors with the appointment of Bob McFarland as a director on January 27, 2023.

ASTROTECH APPOINTS BOB MCFARLAND TO BOARD OF DIRECTORS

Retrieved on: 
Wednesday, February 1, 2023
Science, Federation, Veterans' affairs, Assistant, Federal Business Census, Dell, Astrotech Corporation, Computer, LeTourneau University, Acquisition, Lagos State Ministry of Tourism and Inter-governmental Relations, Retirement, ASTC, OTC, McFarland, United States Department of Veterans Affairs, Adviser, FDA, Beijing Information Science & Technology University, Information, Business, Growth, Information technology, Management, Astrotech, Veteran

AUSTIN, TX, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Astrotech Corporation (Nasdaq: ASTC) announced today that it has increased the size of its Board of Directors from four to five directors and has appointed Bob McFarland as a director of the Company.

Key Points: 
  • AUSTIN, TX, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Astrotech Corporation (Nasdaq: ASTC) announced today that it has increased the size of its Board of Directors from four to five directors and has appointed Bob McFarland as a director of the Company.
  • Mr. McFarland brings to Astrotech’s Board extensive executive management experience with domestic and international enterprises, with a focus on information technology.
  • Mr. McFarland stated, “I am honored to join the Board of Astrotech.
  • “We are pleased to welcome Bob to the Astrotech Board.